A recent article in The New York Times reported on a cost-control exception provided to Amgen, the world’s largest biotechnology firm, hidden in the Senate's final "fiscal cliff" bill. According to the report, the sweet deal was engineered by three U.S. Senators and will cost taxpayers half a billion dollars. Bill talks to U.S. Representative Peter Welch (D-VT) about the bi-partisan bill he recently sponsored to repeal that giveaway, and the political factors that allow such crony capitalism to occur.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…